An additional promising approach demonstrated that exogenous IL-7 added to T cells co-cultured with tumor cells inhibited loss of CD28, a feature of replicative senescence, and allowed normal proliferative capacity and IL-2 production [53]. Here, IL2 is linked to neoplasm.